IP Library › Patent Application 14657165
Patent Application
App. No. 14/657,165

ARRANGING INTERACTION AND BACK PRESSURE CHAMBERS FOR MICROFLUIDIZATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/657,165
Abstract

An improved method for the manufacture of an oil-in-water emulsion comprises using a microfluidisation device whose interaction chamber comprises a plurality of Z-type channels upstream of a back pressure chamber.

Claims (6)

1 . A microfluidization apparatus comprising an interaction chamber comprising at least one intensifier pump, and a back pressure chamber, wherein the interaction chamber and the back pressure chamber both comprise a plurality of fixed geometry channels and wherein the back pressure chamber is located downstream of the interaction chamber.

2 . The apparatus of claim 1 , wherein the channels in the interaction chamber include a plurality of substantially right-angled corners.

3 . The apparatus of claim 2 , wherein the channels in the interaction chamber include two substantially right-angled corners.

4 . The apparatus of claim 1 , wherein the fixed geometry of the channels in the interaction chamber is Z-type geometry.

5 . The apparatus of claim 1 , wherein the interaction chamber provides a shear rate in excess of 1×10 6 s −1 .

6 . A method for the manufacture of an oil-in-water emulsion comprising the step of passing a first emulsion having a first average oil droplet size through a microfluidization apparatus according to claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2016
From: RUECKL, HARALD; SCHEFFCZIK, HANNO
To: NOVARTIS VACCINES AND DIAGNOSTICS GMBH
Reel/Frame 038383/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2016
From: NOVARTIS VACCINES AND DIAGNOSTICS GMBH
To: NOVARTIS AG
Reel/Frame 038383/0347 →